Dosing completed in Phase 1 study of budoprutug subcutaneous formulation, with data expected in H1 2026 Budoprutug clinical trials ongoing in pMN, ITP, and SLE, with initial data from all three trials ...

HUTCHMED divested a 45.0% equity interest in SHPL for $608.5 million in cash in April 2025, retaining a 5.0% equity interest. As a result, HUTCHMED’s share of equity in earnings of SHPL in 2025 ...

When WSDOT closed two lanes of the northbound 1st Avenue South Bridge after an inspection revealed problems 2+ weeks ago, an update was promised by this Friday. Today, we have it - a repair plan ...

A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.

In contemporary South Asian crises, velocity matters more than military power. Velocity means how fast responsibility is assigned, actions are authorized, ...

Phase One of the historic site’s Visitors Center expansion is officially complete, marking the first major renovation of the building since 1993.

The Jonathan Kuminga era is in its honeymoon phase in Atlanta and things are going really well at the moment. The Hawks are 3-0 since Kuminga was available to p ...

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...

The first of four phases of homes in Toll Brothers’ Havenwood residential development was given the green light by Flower ...

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

California’s long-delayed high-speed rail released a new budget plan, touting a few billion in savings but failing to ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.